Related Experiment Videos
Atropine in keratoplasty for keratoconus
1Department of Ophthalmology, Ichilov Hospital Tel Aviv, Israel.
Cornea
|September 1, 1991
Summary
Routine use of 1% atropine after keratoplasty for keratoconus did not cause permanent mydriasis in patients. This study suggests warnings against strong mydriatics in such cases may be unwarranted.
Area of Science:
- Ophthalmology
- Corneal Surgery
Background:
- Keratoplasty is a surgical procedure to restore vision in patients with corneal diseases like keratoconus.
- Historically, concerns existed regarding the use of mydriatics, such as atropine, post-keratoplasty due to potential side effects.
Purpose of the Study:
- To evaluate the safety and efficacy of routine 1% atropine use following keratoplasty for keratoconus.
- To determine if permanent mydriasis occurs after administering atropine post-keratoplasty.
Main Methods:
- A prospective study involving 76 consecutive patients (83 eyes) undergoing keratoplasty for keratoconus.
- 1% atropine was administered routinely at the conclusion of each surgical procedure.
Main Results:
- No instances of permanent mydriasis were observed in any of the patients.
- The previously reported syndrome of fixed, dilated pupils after atropine in keratoplasty was not encountered.
Conclusions:
- The routine use of 1% atropine at the end of keratoplasty for keratoconus appears safe.
- Existing warnings against the use of strong mydriatics in this context may be unnecessary based on these findings.